PRAMIPEXOLE
pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet, 30
PRAMIPEXOLE (14556D)
14556D
Body System:
Manner of administration:Oral
Restriction
Indication: Parkinson disease
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $105.40 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||